{"brief_title": "Open-label Adjunctive Zonisamide for Bipolar Disorder", "brief_summary": "To study the safety and efficacy of zonisamide as adjunctive therapy for children and adolescents with bipolar I or II disorder.", "condition": ["Bipolar Disorders"], "intervention_type": ["Drug"], "intervention_name": ["zonisamide"], "criteria": "- Bipolar I/II - Average intelligence - Taking at least one, but no more than two mood stabilizers", "gender": "All", "minimum_age": "6 Years", "maximum_age": "17 Years", "healthy_volunteers": "No", "keyword": "BIPOLAR", "mesh_term": ["Bipolar Disorder", "Zonisamide"], "id": "NCT00047567"}